Pediatrix Medical Group, Inc. (MD) Financial Statements
Industry: Hospitals (Services)
In fiscal 2025, Pediatrix Medical reported revenue of $1.91B, down 4.9% from $2.01B the year before. Net income was $165.4M (a 8.6% net margin), or $1.94 per diluted share. Operating margin was 10.9%. Operating activities generated $271.1M of cash. At fiscal year end, Pediatrix Medical held $2.25B in total assets against $1.38B in total liabilities, including $375.2M of cash and equivalents.
Open the full interactive Pediatrix Medical financials → Quarterly statements, key ratios, valuation history and price charts.
Pediatrix Medical Key Stats
| Share Price | $26.61 |
|---|---|
| Market Cap | $2.17B |
| P/E Ratio | 13.7 |
| Revenue YoY Growth | -4.9% |
| 52-Week Range | $16.05 – $27.39 |
| Shares Outstanding | 79.4 million (basic, 2026 Q2) |
Pediatrix Medical Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $1.73B | $1.91B | $1.97B | $1.99B | $2.01B | $1.91B |
| Operating Income | $98.1M | $202.9M | $172.7M | $7.3M | -$68.7M | $208.8M |
| Pre-Tax Income | $7.1M | $135.2M | $81.4M | -$48.4M | -$101.3M | $216.4M |
| Income Tax | $16.7M | $27.2M | $18.8M | $12.0M | -$2.3M | $51.0M |
| Net Income | -$796.5M | $131.0M | $66.3M | -$60.4M | -$99.1M | $165.4M |
| Diluted EPS | -$9.55 | $1.53 | $0.79 | $0.73 | -$1.19 | $1.94 |
Pediatrix Medical Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $492.9M | $493.8M | $476.2M | $487.8M |
| Net Income | $71.7M | $33.7M | $29.6M | $39.8M |
| Diluted EPS | $0.84 | $0.40 | $0.36 | $0.49 |
Pediatrix Medical Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.12B | $387.4M | $9.8M | $73.3M | $229.9M | $375.2M |
| Current Assets | $1.55B | $840.6M | $428.0M | $483.5M | $639.6M | $763.5M |
| Total Assets | $3.35B | $2.72B | $2.35B | $2.22B | $2.15B | $2.25B |
| Current Liabilities | $444.3M | $427.4M | $427.0M | $388.9M | $434.1M | $458.9M |
| Total Long-Term Debt | $1.70B | $989.7M | $637.2M | $633.3M | $617.7M | $597.3M |
| Total Liabilities | $2.60B | $1.83B | $1.46B | $1.37B | $1.39B | $1.38B |
| Shareholders' Equity | $747.5M | $896.5M | $891.6M | $849.1M | $764.9M | $865.9M |
Pediatrix Medical Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $204.6M | $76.7M | $166.9M | $137.3M | $206.6M | $271.1M |
| Cash From Investing | $815.5M | -$53.1M | -$57.0M | -$48.2M | -$35.4M | -$18.3M |
| Cash From Financing | -$4.2M | -$760.1M | -$487.6M | -$25.7M | -$14.5M | -$107.5M |
Figures from Pediatrix Medical's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Pediatrix Medical financials page for every line item.
Pediatrix Medical Company Profile
| Ticker | MD |
|---|---|
| Exchange | NYSE |
| Industry | Hospitals (Services) |
| Headquarters | Sunrise, Florida |
| Incorporated in | Florida |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000893949 |
Frequently Asked Questions
What was Pediatrix Medical's revenue in fiscal 2025?
Pediatrix Medical (MD) reported revenue of $1.91B for fiscal 2025.
What is Pediatrix Medical's annual revenue history?
Pediatrix Medical's annual revenue by fiscal year: 2020: $1.73B; 2021: $1.91B; 2022: $1.97B; 2023: $1.99B; 2024: $2.01B; 2025: $1.91B.
What was Pediatrix Medical's net income in fiscal 2025?
Pediatrix Medical reported net income of $165.4M for fiscal 2025.
What was Pediatrix Medical's earnings per share (EPS) in fiscal 2025?
Pediatrix Medical's diluted EPS was $1.94 for fiscal 2025 (adjusted for any later stock splits).
What was Pediatrix Medical's revenue last quarter?
In its most recent reported quarter (2026 Q2), Pediatrix Medical reported revenue of $487.8M.
How much debt does Pediatrix Medical have?
Pediatrix Medical reported $597.3M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Pediatrix Medical are outstanding?
Pediatrix Medical reported a weighted average of 79.4 million basic shares outstanding in 2026 Q2.
What is Pediatrix Medical's market cap?
Based on its latest closing price, Pediatrix Medical (MD) has a market capitalization of about $2.17B.
When does Pediatrix Medical's fiscal year end?
Pediatrix Medical's fiscal year end, as registered with the SEC, is December 31.
Where is Pediatrix Medical headquartered?
Pediatrix Medical lists its business address in Sunrise, Florida in its SEC filings.